Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjectsã- A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial.
Circ J
; 85(11): 2063-2070, 2021 10 25.
Article
in En
| MEDLINE
| ID: mdl-33980763
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Asian People
/
Atherosclerosis
/
Antibodies, Monoclonal, Humanized
/
PCSK9 Inhibitors
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Circ J
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
Year:
2021
Document type:
Article